company
GE Healthcare Ireland Limited
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-04-15GE Healthcare Ireland Limited — Class II recall: GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distrib…
- fda_recall · drug_recall2026-04-15GE Healthcare Ireland Limited — Class II recall: GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distrib…
Frequently asked questions
- How many FDA warning letters has GE Healthcare Ireland Limited received?
- Argus HQ has not recorded an FDA warning letter for GE Healthcare Ireland Limited in our current dataset.
- What FDA recalls has GE Healthcare Ireland Limited issued?
- Argus HQ has recorded 2 FDA recalls tied to GE Healthcare Ireland Limited.
- Is GE Healthcare Ireland Limited FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for GE Healthcare Ireland Limited. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

